
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.
LESS PANICKED THAN EARLIER, BUT THAT'S A LOW BAR
The mood after an hour of European stocks trading is slightly less fraught than it was at the start of the day, but that wasn't hard to do.
The Stoxx 600 is down 2.2%, .STOXX clearly not a good thing for any remaining bulls out there, but we haven't fallen through Monday's lows - yet - and U.S. S&P 500 futures, which had been down nearly 2% earlier, are now just 0.2% down. ESc1
Similarly, the 10-year Treasury yield is now only up 9 basis points on the day. US10YT=RR If we'd opened here, that'd seem bad, but it's down from where it was a couple of hours ago, so who knows?
Back in stocks-land, pharma is the stand-out, with the sector down 4.5% .SXDP the biggest sectoral faller in Europe after U.S. President Donald Trump reiterated plans for a "major" tariff on all pharmaceutical imports. The poster child of the declines is AstraZeneca AZN.L down 6.5%.
(Alun John)
FOR EARLIER LIVE MARKETS POSTS:
EUROPE BEFORE THE BELL: SHARE SELLOFF RESUMES, TREASURIES IN FOCUS CLICK HERE
MORNING BID: MARKETS COWER AS 104% TARIFFS ON CHINA BEGIN CLICK HERE